Editas Medicine, Inc.
EDIT
$1.35
$0.0211.58%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -237.09M | -210.57M | -193.45M | -166.13M | -153.22M |
| Total Depreciation and Amortization | 5.81M | 5.89M | 5.81M | 5.93M | 6.06M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 17.55M | 15.45M | 15.32M | 17.04M | 16.57M |
| Change in Net Operating Assets | 3.45M | 7.46M | 7.69M | -3.12M | -1.59M |
| Cash from Operations | -210.28M | -181.76M | -164.63M | -146.28M | -132.18M |
| Capital Expenditure | -8.83M | -9.59M | -6.91M | -4.75M | -4.72M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 170.97M | 203.62M | 14.14M | -26.99M | 988.00K |
| Cash from Investing | 162.15M | 194.03M | 7.23M | -31.74M | -3.73M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 783.00K | 1.03M | 1.03M | 118.23M | 118.04M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 55.24M | -- | -- | -- | -- |
| Cash from Financing | 56.03M | 1.03M | 1.03M | 118.23M | 118.04M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 7.89M | 13.29M | -156.38M | -59.79M | -17.87M |